TRANSlational Cancer Oesophagus Gefitinib study (TRANS-COG)

Not Applicable

Completed

• Conditions: Cancer; pper Gastro-Intestinal Cancer; Malignant neoplasm of oesophagus

• Registration Number: ISRCTN32435732
• Lead Sponsor: niversity of Aberdeen (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2012-03-05
• Last Update Posted: 8 January 2018

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

1. Patients with oesophagogastric cancer must be eligible for and enrolled in the COG trial
2. Ability to provide written informed consent
3. Formalin-fixed and paraffin-embedded (FFPE) tumour material available
4. Male and female participants
5. Lower Age Limit 18 years

Exclusion Criteria

1. Patients not enrolled in COG trial
2. Inability to provide written informed consent
3. No FFPE tumour material available for analysis

Study & Design

• Study Type: Observational
• Study Design: Not specified